Found 5 matching trials
A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia
PHASE3This is a study designed to evaluate the efficacy and safety of lurasidone ...
Location
Borame Medical Center
Safety and Tolerability Study of Drug to Treat Schizophrenia
PHASE2The purpose of this study is to evaluate the long-term safety of SM-13496 i...
Location
Birmingham Psychiatry Pharmaceutical
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia
PHASE2The purpose of this study is to evaluate the efficacy of the drug SM-13496 ...
Location
Birmingham Psychiatry Pharmaceutical
A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia
PHASE2A 1-year outpatient study to test the safety and tolerability of a new medi...
Location
Birmingham Psychiatry Pharmaceutical
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
PHASE3Lurasidone HCl is a compound being developed for the treatment of schizophr...
Location
K&S Professional Research Services, LLC